scispace - formally typeset
X

Xiaoyuan Huang

Researcher at Huazhong University of Science and Technology

Publications -  52
Citations -  827

Xiaoyuan Huang is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Cancer & Oncolytic adenovirus. The author has an hindex of 12, co-authored 46 publications receiving 618 citations.

Papers
More filters
Journal ArticleDOI

Lymphoma endothelium preferentially expresses Tim-3 and facilitates the progression of lymphoma by mediating immune evasion

TL;DR: It is strongly argued that the lymphoma endothelium is not only a vessel system but also a functional barrier facilitating the establishment of lymphoma immune tolerance, which is a potential target for enhancing the efficacy of tumor immunotherapy and controlling metastatic diseases.
Journal ArticleDOI

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis

TL;DR: This study finds that Tim-3 was expressed at a higher level in the clinical cervical cancer cells compared to the CIN and chronic cervicitis controls and suggests that the expression ofTim-3 in tumor cells may be an independent prognostic factor for patients with cervical cancer.
Journal ArticleDOI

The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells.

TL;DR: The data demonstrate that BK channels play an important role in regulating proliferation of human ovarian cancer cells and may induce apoptosis through induction of p21(Cip1) expression in a p53-dependent manner and NS1619 inhibits the proliferation of A2780 cells in a dosage and time dependent manner.
Journal ArticleDOI

Immune checkpoint inhibitors in the treatment of virus-associated cancers

TL;DR: Although there is no clear statistical significance indicates that ICIs are more effective in virus-associated cancers than non-virus infections, the efficacy of checkpoint inhibitors in the treatment of virus-related cancers is promising and provides a good direction for the implementation of individualized precision medicine.